eLife Acceptance Rate
eLife's acceptance rate in context, including how selective the journal really is and what the number leaves out.
Journal evaluation
Want the full picture on eLife?
See scope, selectivity, submission context, and what editors actually want before you decide whether eLife is realistic.
eLife's acceptance rate question doesn't have a straightforward answer anymore. Since 2023, the journal no longer makes accept/reject decisions after peer review. Every paper that passes initial screening is reviewed and published as a "reviewed preprint" with the reviews attached. The traditional concept of acceptance rate no longer applies.
Quick answer
Under the old model (pre-2023), eLife accepted about 15% of submissions. Under the new model, there is no acceptance or rejection. Papers that pass initial editorial screening (~50-60% of submissions) are sent for review and published with reviewer assessments. The initial screening is the only real filter, and it's closer to 40-50% rejection than the old 85%.
How selectivity works now
Stage | What happens | Approximate pass rate |
|---|---|---|
Submission | Paper enters eLife system | 100% |
Initial assessment | Senior editor + reviewing editor evaluate | ~50-60% proceed to review |
Peer review | 2-3 reviewers evaluate and consult | 100% of reviewed papers published |
Assessment published | Significance + Strength of Evidence ratings | All papers rated, none rejected |
Author revision | Optional, no deadline | Authors choose whether to revise |
The key shift: under the old model, eLife rejected ~85% of submissions total (desk + review). Under the new model, ~40-50% are declined at initial assessment, and everything else is published with reviews.
What "published" means under the new model
Being published as a reviewed preprint on eLife is not the same as a traditional journal acceptance. Each paper receives two public ratings:
- Significance: Landmark, Fundamental, Important, or Useful
- Strength of Evidence: Exceptional, Compelling, Convincing, Solid, Incomplete, or Inadequate
A paper rated "Landmark / Exceptional" carries the prestige of a top-tier eLife acceptance under the old model. A paper rated "Useful / Incomplete" is publicly flagged as having significant weaknesses. The reviews and ratings are permanent and visible.
This means eLife's "acceptance" is now more like a grading system than a binary gate. The selectivity hasn't disappeared. It's been redistributed from a yes/no decision to a quality rating that everyone can see.
What this means for your submission decision
The upside
- No desk rejection anxiety (if the initial assessment passes)
- Guaranteed peer review and published feedback
- Public reviews can strengthen your paper's credibility if the assessment is positive
- No APC (eLife is funded by grants and institutional support)
The downside
- A weak assessment rating is public and permanent
- Your institution or funder may not recognize a reviewed preprint as equivalent to a traditional publication
- The paper is publicly visible before you can control the narrative
- Promotion committees may treat eLife reviewed preprints differently from journal acceptances
The honest question to ask yourself
"If the reviewers rate my paper 'Useful / Incomplete,' am I comfortable with that being publicly attached to my work?"
If yes, eLife's model is genuinely valuable for getting fast, constructive feedback. If that prospect feels risky for your career, a traditional journal with binary accept/reject may be safer.
How eLife compares
Journal | Traditional acceptance rate | Model |
|---|---|---|
eLife (new) | N/A (no accept/reject) | Reviewed preprint with public ratings |
eLife (old) | ~15% | Traditional peer review |
Nature Communications | ~20-25% | Traditional |
PLOS Biology | ~15% | Traditional |
PNAS | ~15% (Direct) | Traditional |
Should you submit?
Submit if:
- you're confident the work will receive a strong assessment (Fundamental/Compelling or better)
- you value fast, constructive peer review over binary gatekeeping
- your career context accepts reviewed preprints as valid publications
- you want your reviews and assessment to be publicly visible as credibility signals
Think twice if:
- a weak public assessment would be more damaging than a private rejection
- your institution or funder requires traditional journal acceptance
- you'd rather keep the work private until you control the publication narrative
- Nature Communications or PLOS Biology would give equivalent prestige with traditional acceptance
A free manuscript scan can help assess whether your paper is likely to receive a strong eLife assessment before you submit.
FAQ
What is eLife's acceptance rate?
Under the new model (since 2023), there is no acceptance or rejection. About 50-60% of submissions pass initial assessment and are published as reviewed preprints with public ratings.
Does eLife still have peer review?
Yes. Papers that pass initial assessment receive full peer review from 2-3 experts who consult with each other. The reviews are published alongside the paper.
Is an eLife reviewed preprint the same as a journal publication?
It depends on your institution. Some treat it equivalently; others do not. The distinction matters for promotion, tenure, and grant applications.
Does eLife have an impact factor?
No. eLife voluntarily withdrew from JCR. The last recorded IF was approximately 7.6 (2022).
Sources
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: how selective journals are, how long review takes, and what the submission requirements look like across journals.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Dataset / benchmark
Biomedical Journal Acceptance Rates
A field-organized acceptance-rate guide that works as a neutral benchmark when authors are deciding how selective to target.
Reference table
Journal Submission Specs
A high-utility submission table covering word limits, figure caps, reference limits, and formatting expectations.
Before you upload
Want the full picture on eLife?
Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.
These pages attract evaluation intent more than upload-ready intent.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- Is eLife a Good Journal? What the 2023 Model Change Means for Authors
- eLife Review Time: What to Expect Under the New Model
- How to Avoid Desk Rejection at eLife in 2026
- eLife Impact Factor 2026: Why It's No Longer Listed
- eLife Pre-Submission Checklist: Is Your Paper Ready for the Reviewed Preprint Model?
- eLife vs PLOS ONE: Which Should You Choose in 2026?
Supporting reads
Conversion step
Want the full picture on eLife?
These pages attract evaluation intent more than upload-ready intent.